The Hain Celestial Group, Inc(NASDAQ:HAIN)
The Hain Celestial Group, Inc. manufactures, markets, and sells organic and natural products in United States, United Kingdom, and internationally. It operates through two segments, North America and International. The company offers infant formula; infant, toddler, and kids food; plant-based bevera...
Website: http://www.hain.com
Founded: 1993
Full Time Employees: 4,287
Sector: Consumer Defensive
Industry: Packaged Foods
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net sales | 338,357,000 | 384,120,000 | 367,883,000 | 363,348,000 | 390,351,000 | 411,485,000 | 394,596,000 | 418,799,000 | 438,358,000 | 454,100,000 | 425,029,000 | 447,841,000 | 455,243,000 | 454,208,000 | 439,351,000 | 457,010,000 | 502,939,000 | 476,941,000 | 454,903,000 | 450,653,000 | 492,604,000 | 528,418,000 | 752,589,000 |
yoy | -13.32% | -6.65% | -6.77% | -13.24% | -10.95% | -9.38% | -7.16% | -6.48% | -3.71% | -0.02% | -3.26% | -2.01% | -9.48% | -4.77% | -3.42% | 1.41% | 2.10% | -9.74% | -39.55% | ||||
qoq | -11.91% | 4.41% | 1.25% | -6.92% | -5.14% | 4.28% | -5.78% | -4.46% | -3.47% | 6.84% | -5.09% | -1.63% | 0.23% | 3.38% | -3.86% | -9.13% | 5.45% | 4.84% | 0.94% | -8.52% | -6.78% | -29.79% | |
cost of sales | 267,965,000 | 309,681,000 | 299,805,000 | 289,002,000 | 305,701,000 | 318,033,000 | 312,986,000 | 320,796,000 | 341,687,000 | 351,885,000 | 341,086,000 | 347,098,000 | 357,764,000 | 350,351,000 | 345,016,000 | 367,985,000 | 387,236,000 | 359,646,000 | 349,485,000 | 338,073,000 | 362,698,000 | 398,453,000 | 575,026,000 |
gross profit | 70,392,000 | 74,439,000 | 68,078,000 | 74,346,000 | 84,650,000 | 93,452,000 | 81,610,000 | 98,003,000 | 96,671,000 | 102,215,000 | 83,943,000 | 100,743,000 | 97,479,000 | 103,857,000 | 94,335,000 | 89,025,000 | 115,703,000 | 117,295,000 | 105,418,000 | 112,580,000 | 129,906,000 | 129,965,000 | 177,563,000 |
yoy | -16.84% | -20.35% | -16.58% | -24.14% | -12.43% | -8.57% | -2.78% | -2.72% | -0.83% | -1.58% | -11.02% | 13.16% | -15.75% | -11.46% | -10.51% | -20.92% | -10.93% | -9.75% | -40.63% | ||||
qoq | -5.44% | 9.34% | -8.43% | -12.17% | -9.42% | 14.51% | -16.73% | 1.38% | -5.42% | 21.77% | -16.68% | 3.35% | -6.14% | 10.09% | 5.96% | -23.06% | -1.36% | 11.27% | -6.36% | -13.34% | -0.05% | -26.81% | |
gross margin % | 20.80% | 19.38% | 18.51% | 20.46% | 21.69% | 22.71% | 20.68% | 23.40% | 22.05% | 22.51% | 19.75% | 22.50% | 21.41% | 22.87% | 21.47% | 19.48% | 23.01% | 24.59% | 23.17% | 24.98% | 26.37% | 24.60% | 23.59% |
selling, general and administrative expenses | 59,078,000 | 60,903,000 | 65,512,000 | 67,416,000 | 62,934,000 | 70,155,000 | 71,328,000 | 72,279,000 | 66,716,000 | 73,952,000 | 77,169,000 | 66,878,000 | 75,047,000 | 72,357,000 | 74,951,000 | 70,790,000 | 75,750,000 | 80,136,000 | 73,989,000 | 62,082,000 | 74,223,000 | 83,620,000 | 82,607,000 |
goodwill impairment | 31,018,000 | 119,908,000 | 227,364,000 | 110,251,000 | 91,267,000 | ||||||||||||||||||
long-lived asset and intangibles impairment | 15,047,000 | 10,507,250 | 24,012,000 | 1,600,000 | 244,000 | 25,179,000 | |||||||||||||||||
productivity and transformation costs | 4,066,000 | 5,234,000 | 8,219,000 | 5,033,000 | 7,289,000 | 4,190,000 | 5,018,000 | 7,294,000 | 7,175,000 | 6,869,000 | 6,403,000 | 1,592,000 | 3,933,000 | 986,000 | 773,000 | 1,726,000 | 1,679,000 | 2,786,000 | 3,983,000 | 6,528,000 | 4,553,000 | 6,016,000 | |
amortization of acquired intangible assets | 3,314,000 | 1,199,000 | 1,212,000 | 1,300,000 | 1,243,000 | 1,753,000 | 2,180,000 | 1,061,000 | 1,255,000 | 1,509,000 | 1,955,000 | 1,601,000 | 2,842,000 | 2,785,000 | 2,788,000 | 2,960,000 | 3,110,000 | 2,049,000 | 2,095,000 | 2,160,000 | 2,145,000 | 2,193,000 | |
proceeds from insurance claim | -25,900,000 | -49,000 | -196,000 | -592,000 | |||||||||||||||||||
operating income | -42,131,000 | -98,822,000 | -6,865,000 | -251,678,000 | -121,079,000 | -91,899,000 | 3,053,000 | 12,012,000 | -27,901,000 | -781,000 | -2,278,000 | 12,094,000 | -140,926,000 | 27,389,000 | 15,823,000 | 11,949,000 | 35,164,000 | 32,021,000 | 25,547,000 | 41,566,000 | 49,577,000 | 12,957,000 | 87,722,000 |
yoy | -65.20% | 7.53% | -324.86% | -2195.22% | 333.96% | 11666.84% | -234.02% | -0.68% | -80.20% | -102.85% | -114.40% | 1.21% | -500.77% | -14.47% | -38.06% | -71.25% | -29.07% | 147.13% | -70.88% | ||||
qoq | -57.37% | 1339.50% | -97.27% | 107.86% | 31.75% | -3110.12% | -74.58% | -143.05% | 3472.47% | -65.72% | -118.84% | -108.58% | -614.54% | 73.10% | 32.42% | -66.02% | 9.82% | 25.34% | -38.54% | -16.16% | 282.63% | -85.23% | |
operating margin % | -12.45% | -25.73% | -1.87% | -69.27% | -31.02% | -22.33% | 0.77% | 2.87% | -6.36% | -0.17% | -0.54% | 2.70% | -30.96% | 6.03% | 3.60% | 2.61% | 6.99% | 6.71% | 5.62% | 9.22% | 10.06% | 2.45% | 11.66% |
interest and other financing expense | 13,914,000 | 15,662,000 | 15,499,000 | 12,841,000 | 11,866,000 | 12,800,000 | 13,746,000 | 13,704,000 | 14,127,000 | 16,138,000 | 13,244,000 | 13,873,000 | 13,421,000 | 10,812,000 | 7,677,000 | 4,898,000 | 3,224,000 | 2,592,000 | 1,856,000 | 1,834,000 | 2,030,000 | 2,337,000 | |
other expense | 49,518,000 | -997,000 | -656,000 | -1,559,000 | 1,182,000 | -4,040,000 | 5,292,000 | 4,327,000 | 100,000 | -603,250 | 439,000 | -810,000 | -712,000 | -9,215,000 | 1,566,000 | -1,045,000 | |||||||
loss before income taxes and equity in net loss of equity-method investees | -105,563,000 | -113,487,000 | -21,708,000 | -262,960,000 | -134,127,000 | -100,659,000 | -15,985,000 | -18,565,500 | -42,128,000 | ||||||||||||||
provision for income taxes | 759,000 | 2,386,000 | -1,256,000 | 9,551,000 | -505,000 | 2,728,000 | 3,523,000 | -3,292,000 | 5,100,000 | -4,249,000 | -5,379,000 | 16,421,000 | -39,587,000 | 6,357,000 | 2,631,000 | 3,291,000 | 7,738,000 | 7,145,000 | 4,542,000 | 7,896,000 | 11,797,000 | 8,438,000 | 21,379,000 |
equity in net loss of equity-method investees | 21,000 | 133,000 | 173,000 | 104,000 | 966,000 | 588,000 | 155,000 | 210,000 | 966,000 | 907,000 | 498,000 | -92,000 | 528,000 | 316,000 | 382,000 | 1,528,000 | 383,000 | 465,000 | 526,000 | 566,000 | -70,000 | 1,076,000 | 31,000 |
net income | -106,343,000 | -116,006,000 | -20,625,000 | -272,615,000 | -134,588,000 | -103,975,000 | -19,663,000 | -2,937,000 | -48,194,000 | -13,535,000 | -10,376,000 | -18,699,000 | -115,727,000 | 10,966,000 | 6,923,000 | 3,042,000 | 24,531,000 | 30,889,000 | 19,411,000 | 40,485,000 | 34,254,000 | 2,140,000 | 56,947,000 |
yoy | -20.99% | 11.57% | 4.89% | 9182.09% | 179.26% | 668.19% | 89.50% | -84.29% | -58.36% | -223.43% | -249.88% | -714.69% | -571.76% | -64.50% | -64.33% | -92.49% | -28.39% | 1343.41% | -65.91% | ||||
qoq | -8.33% | 462.45% | -92.43% | 102.56% | 29.44% | 428.79% | 569.49% | -93.91% | 256.07% | 30.45% | -44.51% | -83.84% | -1155.33% | 58.40% | 127.58% | -87.60% | -20.58% | 59.13% | -52.05% | 18.19% | 1500.65% | -96.24% | |
net income margin % | -31.43% | -30.20% | -5.61% | -75.03% | -34.48% | -25.27% | -4.98% | -0.70% | -10.99% | -2.98% | -2.44% | -4.18% | -25.42% | 2.41% | 1.58% | 0.67% | 4.88% | 6.48% | 4.27% | 8.98% | 6.95% | 0.40% | 7.57% |
net loss per common share: | |||||||||||||||||||||||
basic | -1,170 | -1,280 | -230 | -3,020 | -1,490 | -1,150 | -220 | -200 | -540 | ||||||||||||||
diluted | -1,170 | -1,280 | -230 | -3,020 | -1,490 | -1,150 | -220 | -200 | -540 | ||||||||||||||
shares used in the calculation of net loss per common share: | |||||||||||||||||||||||
basic | 90,993,000 | 90,655,000 | 90,309,000 | 47,000 | 90,247,000 | 90,132,000 | 89,861,000 | 32,000 | 89,832,000 | 89,811,000 | 89,512,000 | 27,000 | 89,421,000 | 89,380,000 | 89,307,000 | -1,110,000 | 91,139,000 | 94,036,000 | 97,121,000 | -267,000 | 99,831,000 | 100,117,000 | |
diluted | 90,993,000 | 90,655,000 | 90,309,000 | 47,000 | 90,247,000 | 90,132,000 | 89,861,000 | 32,000 | 89,832,000 | 89,811,000 | 89,512,000 | 27,000 | 89,421,000 | 89,578,000 | 89,493,000 | -1,174,000 | 91,310,000 | 94,808,000 | 97,438,000 | -63,000 | 101,596,000 | 100,562,000 | |
intangibles and long-lived asset impairment | 11,917,000 | 17,986,000 | 5,357,000 | 49,426,000 | 18,578,000 | 156,583,000 | |||||||||||||||||
long-lived asset impairment | 31,000 | 20,666,000 | 694,000 | 340,000 | 303,000 | ||||||||||||||||||
other income | -42,000 | -265,000 | -1,062,000 | -1,790,000 | -9,070,000 | -788,000 | |||||||||||||||||
income before income taxes and equity in net loss of equity-method investees | -16,877,000 | -31,802,750 | -154,786,000 | 17,639,000 | |||||||||||||||||||
net income per common share: | |||||||||||||||||||||||
basic | -150 | -120 | -272.5 | -1,290 | 120 | 80 | 550 | ||||||||||||||||
diluted | -150 | -120 | -272.5 | -1,290 | 120 | 80 | 550 | ||||||||||||||||
shares used in the calculation of net income per common share: | |||||||||||||||||||||||
basic | 90,993,000 | 90,655,000 | 90,309,000 | 47,000 | 90,247,000 | 90,132,000 | 89,861,000 | 32,000 | 89,832,000 | 89,811,000 | 89,512,000 | 27,000 | 89,421,000 | 89,380,000 | 89,307,000 | -1,110,000 | 91,139,000 | 94,036,000 | 97,121,000 | -267,000 | 99,831,000 | 100,117,000 | |
diluted | 90,993,000 | 90,655,000 | 90,309,000 | 47,000 | 90,247,000 | 90,132,000 | 89,861,000 | 32,000 | 89,832,000 | 89,811,000 | 89,512,000 | 27,000 | 89,421,000 | 89,578,000 | 89,493,000 | -1,174,000 | 91,310,000 | 94,808,000 | 97,438,000 | -63,000 | 101,596,000 | 100,562,000 | |
income from operations before income taxes and equity in net loss of equity-method investees | -15,257,000 | 9,936,000 | |||||||||||||||||||||
income from continuing operations before income taxes and equity in net loss of equity-method investees | 7,861,000 | 32,652,000 | 38,499,000 | 24,479,000 | 48,947,000 | 45,981,000 | 11,665,000 | ||||||||||||||||
net income from continuing operations | 3,042,000 | 24,531,000 | 30,889,000 | 19,411,000 | 40,485,000 | 34,254,000 | 2,151,000 | ||||||||||||||||
net income from discontinued operations, net of tax | -11,000 | ||||||||||||||||||||||
net income per common share: | |||||||||||||||||||||||
basic net income per common share from continuing operations | 40 | 270 | 330 | 200 | 410 | 340 | 20 | ||||||||||||||||
basic net income per common share from discontinued operations | |||||||||||||||||||||||
basic net income per common share | 40 | 270 | 330 | 200 | 410 | 340 | 20 | ||||||||||||||||
diluted net income per common share from continuing operations | 40 | 270 | 330 | 200 | 400 | 340 | 20 | ||||||||||||||||
diluted net income per common share from discontinued operations | |||||||||||||||||||||||
diluted net income per common share | 40 | 270 | 330 | 200 | 400 | 340 | 20 | ||||||||||||||||
amortization of acquired intangibles | 4,736,000 | ||||||||||||||||||||||
acquisition related expenses, restructuring and integration charges | 2,498,000 | ||||||||||||||||||||||
interest and other expenses | 9,365,000 | ||||||||||||||||||||||
income before income taxes and equity in earnings of equity-method investees | 78,357,000 | ||||||||||||||||||||||
weighted-average common shares outstanding: | |||||||||||||||||||||||
basic | 103,017,000 | ||||||||||||||||||||||
diluted | 104,161,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||
current assets: | |||||||||||||||||||||||
cash and cash equivalents | 44,311,000 | 68,017,000 | 47,886,000 | 54,355,000 | 44,425,000 | 56,200,000 | 56,853,000 | 54,307,000 | 49,549,000 | 53,672,000 | 38,280,000 | 53,364,000 | 43,682,000 | 43,437,000 | 51,794,000 | 65,512,000 | 57,808,000 | 77,202,000 | 28,962,000 | 75,871,000 | 53,014,000 | 46,813,000 | 177,100,000 |
accounts receivables | 138,816,000 | 174,064,000 | 170,731,000 | 154,440,000 | 172,310,000 | 178,312,000 | 188,190,000 | 179,190,000 | 191,192,000 | 192,538,000 | 158,094,000 | 160,948,000 | 179,114,000 | 177,058,000 | 172,692,000 | 170,661,000 | 158,734,000 | 163,672,000 | 181,048,000 | 174,066,000 | 190,737,000 | 185,576,000 | 350,408,000 |
inventories | 159,071,000 | 215,742,000 | 229,498,000 | 248,731,000 | 248,956,000 | 260,525,000 | 270,418,000 | 274,128,000 | 281,399,000 | 295,276,000 | 313,335,000 | 310,341,000 | 316,345,000 | 324,525,000 | 315,882,000 | 308,034,000 | 294,428,000 | 289,239,000 | 280,176,000 | 285,410,000 | 313,898,000 | 311,988,000 | 403,318,000 |
prepaid expenses and other current assets | 84,230,000 | 76,435,000 | 46,131,000 | 43,169,000 | 53,099,000 | 53,450,000 | 48,570,000 | 49,434,000 | 49,813,000 | 57,954,000 | 56,044,000 | 65,128,000 | 58,719,000 | 58,781,000 | 53,499,000 | 54,079,000 | 45,308,000 | 45,505,000 | 38,496,000 | 39,834,000 | 38,648,000 | 39,250,000 | 49,513,000 |
assets held for sale | 9,437,000 | 30,137,000 | 28,773,000 | 29,603,000 | 33,333,000 | 1,250,000 | 1,250,000 | 1,500,000 | 1,840,000 | 1,840,000 | 3,313,000 | 3,354,000 | 3,642,000 | 1,874,000 | 52,828,000 | ||||||||
total current assets | 435,865,000 | 564,395,000 | 523,019,000 | 530,298,000 | 552,123,000 | 548,487,000 | 564,031,000 | 557,059,000 | 571,953,000 | 599,440,000 | 565,753,000 | 591,031,000 | 599,110,000 | 605,301,000 | 595,707,000 | 600,126,000 | 559,591,000 | 578,972,000 | 532,324,000 | 577,055,000 | 596,297,000 | 636,455,000 | 1,001,366,000 |
property, plant and equipment | 188,104,000 | 250,500,000 | 255,992,000 | 264,730,000 | 254,079,000 | 250,735,000 | 266,947,000 | 261,730,000 | 264,470,000 | 273,451,000 | 285,972,000 | 296,325,000 | 296,433,000 | 294,635,000 | 281,540,000 | 297,405,000 | 312,819,000 | 320,047,000 | 312,426,000 | 312,777,000 | 311,342,000 | 296,013,000 | 382,830,000 |
goodwill | 288,297,000 | 378,042,000 | 498,159,000 | 500,961,000 | 712,727,000 | 825,624,000 | 936,341,000 | 929,304,000 | 936,135,000 | 939,561,000 | 928,375,000 | 938,640,000 | 931,729,000 | 927,078,000 | 912,278,000 | 933,796,000 | 950,820,000 | 956,283,000 | 863,348,000 | 871,067,000 | 877,723,000 | 876,993,000 | 1,219,725,000 |
trademarks and other intangible assets | 178,286,000 | 194,293,000 | 207,321,000 | 210,905,000 | 225,475,000 | 223,652,000 | 250,179,000 | 244,799,000 | 250,265,000 | 295,011,000 | 290,867,000 | 298,105,000 | 314,536,000 | 470,956,000 | 463,161,000 | 477,533,000 | 492,939,000 | 500,093,000 | 308,588,000 | 314,895,000 | 324,791,000 | 326,272,000 | 659,267,000 |
operating lease right-of-use assets | 51,340,000 | 67,348,000 | 69,993,000 | 71,171,000 | 71,326,000 | 80,726,000 | 85,029,000 | 86,634,000 | 87,599,000 | 91,388,000 | 102,540,000 | 95,894,000 | 98,306,000 | 101,374,000 | 115,517,000 | 114,691,000 | 88,636,000 | 91,739,000 | 88,387,000 | 92,010,000 | 90,130,000 | 89,971,000 | |
other assets | 20,829,000 | 22,832,000 | 28,415,000 | 25,213,000 | 22,367,000 | 24,397,000 | 22,202,000 | 27,794,000 | 28,356,000 | 23,372,000 | 31,091,000 | 25,846,000 | 19,990,000 | 25,554,000 | 34,960,000 | 20,377,000 | 20,619,000 | 21,826,000 | 20,474,000 | 21,187,000 | 22,263,000 | 22,969,000 | 33,458,000 |
total assets | 1,162,721,000 | 1,477,410,000 | 1,582,899,000 | 1,603,278,000 | 1,844,055,000 | 1,960,543,000 | 2,134,809,000 | 2,117,548,000 | 2,149,234,000 | 2,233,634,000 | 2,216,896,000 | 2,258,639,000 | 2,272,824,000 | 2,438,158,000 | 2,416,990,000 | 2,458,384,000 | 2,441,480,000 | 2,485,369,000 | 2,142,265,000 | 2,205,908,000 | 2,239,888,000 | 2,265,599,000 | 3,316,860,000 |
liabilities and stockholders’ equity | |||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||
accounts payable | 151,926,000 | 198,475,000 | 175,667,000 | 188,307,000 | 210,052,000 | 198,541,000 | 184,969,000 | 188,220,000 | 179,068,000 | 169,054,000 | 142,291,000 | 134,780,000 | 146,340,000 | 153,677,000 | 157,916,000 | 174,765,000 | 176,699,000 | 179,808,000 | 172,733,000 | 171,947,000 | 210,223,000 | 216,782,000 | 280,042,000 |
accrued expenses and other current liabilities | 129,199,000 | 103,190,000 | 81,321,000 | 68,426,000 | 70,530,000 | 83,168,000 | 88,160,000 | 85,714,000 | 85,736,000 | 90,857,000 | 96,731,000 | 88,520,000 | 95,841,000 | 85,168,000 | 91,906,000 | 86,833,000 | 98,181,000 | 110,030,000 | 123,296,000 | 117,957,000 | 120,498,000 | 118,732,000 | 89,965,000 |
current portion of long-term debt | 549,184,000 | 704,315,000 | 7,647,000 | 7,653,000 | 7,554,000 | 7,564,000 | 7,567,000 | 7,569,000 | 7,569,000 | 7,569,000 | 7,568,000 | 7,567,000 | 7,575,000 | 7,602,000 | 7,657,000 | 7,705,000 | 7,774,000 | 7,834,000 | 335,000 | 530,000 | 699,000 | 899,000 | 41,552,000 |
liabilities related to assets held for sale | 4,594,000 | 10,554,000 | 12,202,000 | 12,987,000 | 16,599,000 | 29,292,000 | |||||||||||||||||
total current liabilities | 834,903,000 | 1,016,534,000 | 276,837,000 | 277,373,000 | 304,735,000 | 289,273,000 | 280,696,000 | 281,503,000 | 272,373,000 | 267,480,000 | 246,590,000 | 230,867,000 | 249,756,000 | 246,447,000 | 257,479,000 | 269,303,000 | 282,654,000 | 297,672,000 | 296,364,000 | 290,434,000 | 331,420,000 | 365,705,000 | 411,559,000 |
long-term debt, less current portion | 312,000 | 388,000 | 708,563,000 | 697,168,000 | 701,401,000 | 721,076,000 | 732,799,000 | 736,523,000 | 769,948,000 | 801,675,000 | 807,401,000 | 821,181,000 | 848,982,000 | 870,800,000 | 891,123,000 | 880,938,000 | 827,771,000 | 731,613,000 | 345,414,000 | 230,492,000 | 255,540,000 | 293,332,000 | 940,462,000 |
deferred income taxes | 38,349,000 | 40,923,000 | 41,404,000 | 40,332,000 | 41,652,000 | 45,571,000 | 45,397,000 | 47,826,000 | 52,310,000 | 52,900,000 | 61,006,000 | 72,086,000 | 51,155,000 | 95,131,000 | 97,813,000 | 95,044,000 | 86,120,000 | 82,020,000 | 40,345,000 | 42,639,000 | 36,103,000 | 32,098,000 | 21,027,000 |
operating lease liabilities, noncurrent portion | 46,303,000 | 61,683,000 | 63,798,000 | 65,284,000 | 66,000,000 | 74,817,000 | 78,905,000 | 80,863,000 | 82,435,000 | 86,022,000 | 97,165,000 | 90,014,000 | 91,885,000 | 92,587,000 | 109,858,000 | 107,481,000 | 81,379,000 | 84,219,000 | 82,176,000 | 85,929,000 | 83,564,000 | 83,268,000 | |
other noncurrent liabilities | 27,308,000 | 27,637,000 | 47,308,000 | 48,116,000 | 33,562,000 | 25,073,000 | 33,351,000 | 27,920,000 | 27,681,000 | 29,736,000 | 23,740,000 | 26,584,000 | 24,571,000 | 24,552,000 | 19,322,000 | 22,450,000 | 19,512,000 | 25,989,000 | 29,210,000 | 33,531,000 | 31,579,000 | 36,547,000 | 4,830,000 |
total liabilities | 947,175,000 | 1,147,165,000 | 1,137,910,000 | 1,128,273,000 | 1,147,350,000 | 1,155,810,000 | 1,171,148,000 | 1,174,635,000 | 1,204,747,000 | 1,237,813,000 | 1,235,902,000 | 1,240,732,000 | 1,266,349,000 | 1,329,517,000 | 1,375,595,000 | 1,375,216,000 | 1,297,436,000 | 1,221,513,000 | 793,509,000 | 683,025,000 | 738,206,000 | 810,950,000 | 1,502,835,000 |
commitments and contingencies | |||||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||
preferred stock - .01 par value... | |||||||||||||||||||||||
common stock - .01 par value... | 1,135,000 | 1,135,000 | 1,126,000 | 1,125,000 | 1,124,000 | 1,124,000 | 1,120,000 | 1,119,000 | 1,119,000 | 1,118,000 | 1,116,000 | 1,113,000 | 1,113,000 | 1,113,000 | 1,112,000 | 1,111,000 | 1,111,000 | 1,110,000 | 1,096,000 | 1,096,000 | 1,096,000 | 1,095,000 | 1,066,000 |
additional paid-in capital | 1,242,584,000 | 1,241,446,000 | 1,240,405,000 | 1,238,402,000 | 1,239,675,000 | 1,236,702,000 | 1,233,129,000 | 1,230,253,000 | 1,227,684,000 | 1,224,667,000 | 1,221,291,000 | 1,217,549,000 | 1,213,783,000 | 1,210,555,000 | 1,207,120,000 | 1,203,126,000 | 1,199,804,000 | 1,195,959,000 | 1,191,817,000 | 1,187,530,000 | 1,183,759,000 | 1,180,062,000 | 1,103,357,000 |
retained (deficit) earnings | -196,296,000 | -89,953,000 | |||||||||||||||||||||
accumulated other comprehensive loss | -101,387,000 | -91,893,000 | -92,378,000 | -81,053,000 | -133,273,000 | -156,983,000 | -99,409,000 | -137,245,000 | -136,072,000 | -130,025,000 | -155,623,000 | -126,216,000 | -152,945,000 | -163,346,000 | -216,944,000 | -164,482,000 | -110,350,000 | -94,230,000 | -93,974,000 | -73,011,000 | -77,682,000 | -97,343,000 | -107,577,000 |
stockholders’ equity: - sum | 946,036,000 | 1,060,735,000 | 1,175,206,000 | 1,205,152,000 | 1,426,819,000 | 1,534,724,000 | 1,692,696,000 | 1,671,646,000 | 1,673,187,000 | 1,724,410,000 | 1,708,969,000 | 1,745,007,000 | 1,733,211,000 | 1,835,309,000 | 1,767,309,000 | 1,808,853,000 | 1,856,621,000 | 1,844,364,000 | 1,809,575,000 | 1,806,840,000 | 1,757,913,000 | 1,700,300,000 | 1,882,609,000 |
less: treasury stock, at cost, 22,463 and 22,207 shares, respectively | -730,490,000 | -730,490,000 | |||||||||||||||||||||
total stockholders’ equity | 215,546,000 | 330,245,000 | 444,989,000 | 475,005,000 | 696,705,000 | 804,733,000 | 963,661,000 | 942,913,000 | 944,487,000 | 995,821,000 | 980,994,000 | 1,017,907,000 | 1,006,475,000 | 1,108,641,000 | 1,041,395,000 | 1,083,168,000 | 1,144,044,000 | 1,263,856,000 | 1,348,756,000 | 1,522,883,000 | 1,501,682,000 | 1,454,649,000 | 1,814,025,000 |
total liabilities and stockholders’ equity | 1,162,721,000 | 1,477,410,000 | 1,582,899,000 | 1,603,278,000 | 1,844,055,000 | 1,960,543,000 | 2,134,809,000 | 2,117,548,000 | 2,149,234,000 | 2,233,634,000 | 2,216,896,000 | 2,258,639,000 | 2,272,824,000 | 2,438,158,000 | 2,416,990,000 | 2,458,384,000 | 2,441,480,000 | 2,485,369,000 | 2,142,265,000 | 2,205,908,000 | 2,239,888,000 | 2,265,599,000 | 3,316,860,000 |
retained earnings | 26,053,000 | 46,678,000 | 319,293,000 | 453,881,000 | 557,856,000 | 577,519,000 | 580,456,000 | 628,650,000 | 642,185,000 | 652,561,000 | 671,260,000 | 786,987,000 | 776,021,000 | 769,098,000 | 766,056,000 | 741,525,000 | 710,636,000 | 691,225,000 | 650,740,000 | 616,486,000 | 885,763,000 | ||
less: treasury stock, at cost, 22,240 and 22,207 shares, respectively | -730,217,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 22,207 and 22,021 shares, respectively | -730,147,000 | ||||||||||||||||||||||
investments and joint ventures | 5,958,000 | 6,922,000 | 10,080,000 | 10,228,000 | 10,456,000 | 11,411,000 | 12,298,000 | 12,798,000 | 12,720,000 | 13,260,000 | 13,827,000 | 14,456,000 | 16,056,000 | 16,409,000 | 16,718,000 | 16,917,000 | 17,342,000 | 16,926,000 | 20,214,000 | ||||
less: treasury stock, at cost, 22,194 and 22,021 shares, respectively | -730,114,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 22,172 and 22,021 shares, respectively | -729,991,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 22,057 and 22,021 shares, respectively | -729,035,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 22,021 and 21,864 shares, respectively | -728,733,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 22,016 and 21,864 shares, respectively | -728,700,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 22,006 and 21,864 shares, respectively | -728,589,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,950 and 21,864 shares, respectively | -727,975,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,864 and 21,788 shares, respectively | -727,100,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,840 and 21,788 shares, respectively | -726,736,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,837 and 21,788 shares, respectively | -726,668,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,798 and 21,788 shares, respectively | -725,914,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,788 and 10,438 shares, respectively | -725,685,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 21,287 and 10,438 shares, respectively | -712,577,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 17,673 and 10,438 shares, respectively | -580,508,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 14,992 and 10,438 shares, respectively | -460,819,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 10,438 and 7,238 shares, respectively | -283,957,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 9,753 and 7,238 shares, respectively | -256,231,000 | ||||||||||||||||||||||
less: treasury stock, at cost, 9,500 and 7,238 shares, respectively | -245,651,000 | ||||||||||||||||||||||
less: 3,447,946 and 3,229,342 shares of treasury stock, at cost | -68,584,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||
net loss | -106,343,000 | -116,006,000 | -20,625,000 | -272,615,000 | -134,588,000 | -103,975,000 | -19,663,000 | ||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||
depreciation and amortization | 12,484,000 | 11,149,000 | 15,411,000 | 11,357,000 | 10,455,000 | 11,020,000 | 11,427,000 | 10,305,000 | 10,858,000 | 11,197,000 | 12,305,000 | 12,868,000 | 13,784,000 | 12,155,000 | 11,970,000 | 12,453,000 | 12,638,000 | 10,903,000 | 10,855,000 | 11,801,000 | 12,814,000 |
deferred income taxes | -2,664,000 | -183,000 | 160,000 | -1,798,000 | -1,509,000 | -445,000 | -671,000 | -4,597,000 | -1,973,000 | -5,522,000 | -11,269,000 | 18,856,000 | -42,826,000 | -486,000 | -1,497,000 | 1,646,000 | 10,645,000 | -1,166,000 | -2,105,000 | 6,668,000 | 3,124,000 |
equity in net loss of equity-method investees | 21,000 | 133,000 | 173,000 | 104,000 | 966,000 | 588,000 | 155,000 | 210,000 | 966,000 | 907,000 | 498,000 | -92,000 | 528,000 | 316,000 | 382,000 | 1,528,000 | 383,000 | 566,000 | -70,000 | ||
stock-based compensation | 1,138,000 | 1,051,000 | 2,003,000 | -1,273,000 | 2,973,000 | 3,573,000 | 2,876,000 | 2,569,000 | 3,017,000 | 3,376,000 | 3,742,000 | 3,766,000 | 3,228,000 | 3,435,000 | 3,994,000 | 3,322,000 | 3,846,000 | 4,156,000 | 4,287,000 | 3,771,000 | 3,698,000 |
goodwill impairment | 31,018,000 | 227,364,000 | 110,251,000 | ||||||||||||||||||
intangibles and long-lived asset impairment | 15,047,000 | 5,357,000 | 18,578,000 | ||||||||||||||||||
loss on sale of assets | 50,529,000 | -1,142,000 | -886,000 | -5,396,000 | -106,000 | -1,626,000 | 3,934,000 | 3,572,000 | 0 | 0 | 62,000 | ||||||||||
other non-cash items | 1,539,000 | 1,100,000 | 232,000 | 1,365,000 | 1,271,000 | -1,583,000 | 1,085,000 | 160,000 | -21,000 | 1,521,000 | -556,000 | 255,000 | 979,000 | -1,048,000 | -1,457,000 | 547,000 | -669,000 | -141,000 | 2,259,000 | ||
increase in cash attributable to changes in operating assets and liabilities: | |||||||||||||||||||||
accounts receivable | 37,230,000 | -3,882,000 | -15,707,000 | 26,565,000 | 98,000 | 2,467,000 | -3,926,000 | 11,709,000 | -25,000 | -29,497,000 | -1,150,000 | 20,993,000 | -1,390,000 | 3,053,000 | -9,589,000 | -19,497,000 | 1,780,000 | 21,813,000 | -9,443,000 | 17,831,000 | -11,198,000 |
inventories | 27,589,000 | 15,757,000 | 16,210,000 | 7,251,000 | -14,578,000 | 1,691,000 | 2,282,000 | 4,039,000 | 12,266,000 | 22,589,000 | -7,423,000 | 8,723,000 | 10,095,000 | -1,722,000 | -16,907,000 | -20,901,000 | -6,844,000 | 196,000 | 2,277,000 | 21,782,000 | -1,792,000 |
other current assets | -6,643,000 | -29,023,000 | -4,103,000 | 11,393,000 | -597,000 | -5,211,000 | -2,471,000 | 276,000 | 8,948,000 | -3,879,000 | 8,761,000 | -3,286,000 | 786,000 | -2,872,000 | 2,541,000 | 537,000 | -5,870,000 | -6,026,000 | 900,000 | -1,315,000 | 769,000 |
other assets and liabilities | -860,000 | -291,000 | -2,858,000 | 1,881,000 | -471,000 | -669,000 | 579,000 | 1,174,000 | -1,890,000 | 622,000 | -3,198,000 | -950,000 | -682,000 | 2,830,000 | 1,348,000 | 1,000 | -4,481,000 | 3,342,000 | -1,566,000 | 732,000 | 85,000 |
accounts payable and accrued expenses | -21,747,000 | 26,480,000 | 1,510,000 | -33,757,000 | 6,468,000 | 15,822,000 | -6,425,000 | 7,559,000 | 8,896,000 | 12,210,000 | 21,940,000 | -20,502,000 | 3,737,000 | -21,168,000 | -2,764,000 | -3,504,000 | -4,856,000 | -25,392,000 | 13,813,000 | -44,678,000 | -1,956,000 |
net cash from operating activities | 38,338,000 | 36,968,000 | -8,480,000 | -2,648,000 | 4,645,000 | 30,905,000 | -10,787,000 | 39,396,000 | 42,274,000 | 20,655,000 | 14,030,000 | 40,510,000 | 28,961,000 | 2,464,000 | -5,116,000 | ||||||
capital expenditures | -3,789,000 | -6,988,000 | -5,227,000 | -6,224,000 | -6,921,000 | -6,382,000 | -5,757,000 | -8,692,000 | -12,034,000 | -5,829,000 | -6,906,000 | -6,445,000 | -7,379,000 | -6,840,000 | -7,215,000 | ||||||
free cash flows | 34,549,000 | 29,980,000 | -13,707,000 | -8,872,000 | -2,276,000 | 24,523,000 | -16,544,000 | 30,704,000 | 30,240,000 | 14,826,000 | 7,124,000 | 34,065,000 | 21,582,000 | -4,376,000 | -12,331,000 | ||||||
cash flows from investing activities | |||||||||||||||||||||
purchases of property, plant and equipment | -3,789,000 | -6,988,000 | -5,227,000 | -6,224,000 | -6,921,000 | -6,382,000 | -5,757,000 | -8,692,000 | -12,034,000 | -5,829,000 | -6,906,000 | -6,445,000 | -7,379,000 | -6,840,000 | -7,215,000 | -6,026,000 | -5,943,000 | -10,186,000 | -17,810,000 | -18,491,000 | -23,391,000 |
proceeds from sale of assets | 100,988,000 | 1,769,000 | 13,000 | 197,000 | 6,000 | 1,701,000 | 12,066,000 | 8,019,000 | 188,000 | 75,000 | 1,257,000 | 48,000 | 150,000 | 7,512,000 | 96,000 | 1,579,000 | 22,000 | 10,570,000 | 164,000 | ||
investments and joint ventures | 0 | 0 | 0 | 242,000 | 191,000 | ||||||||||||||||
proceeds from termination of net investment hedges | 0 | ||||||||||||||||||||
net cash from investing activities | 97,199,000 | -5,219,000 | -5,214,000 | 3,973,000 | -4,552,000 | -2,111,000 | 6,309,000 | -673,000 | -11,846,000 | -5,754,000 | -5,649,000 | -6,397,000 | -7,229,000 | 914,000 | -6,928,000 | ||||||
cash flows from financing activities | |||||||||||||||||||||
borrowings under bank revolving credit facility | 43,000,000 | 45,000,000 | 68,000,000 | 65,000,000 | 47,000,000 | 50,000,000 | 59,000,000 | 34,000,000 | 30,000,000 | 76,000,000 | 46,000,000 | 53,000,000 | 90,000,000 | 105,000,000 | 80,000,000 | 81,000,000 | 138,000,000 | 420,000,000 | 120,000,000 | 35,000,000 | 56,000,000 |
repayments under bank revolving credit facility | -96,000,000 | -55,000,000 | -54,500,000 | -59,500,000 | -65,000,000 | -60,000,000 | -61,000,000 | -55,000,000 | -60,000,000 | -80,000,000 | -57,000,000 | -79,000,000 | -106,250,000 | -124,875,000 | -69,875,000 | -26,000,000 | -40,000,000 | -325,000,000 | -5,000,000 | -60,000,000 | -94,000,000 |
repayments under term loan | -102,975,000 | -1,875,000 | -1,875,000 | -9,375,000 | -1,875,000 | -1,875,000 | -1,875,000 | -12,575,000 | -1,875,000 | -1,875,000 | -1,875,000 | -1,875,000 | -1,875,000 | ||||||||
payments of other debt | -33,000 | -98,000 | -2,511,000 | -3,503,000 | 21,000 | -21,000 | -21,000 | -21,000 | -21,000 | -20,000 | -3,834,000 | -29,000 | -1,957,000 | -87,000 | -72,000 | -88,000 | -47,000 | ||||
employee shares withheld for taxes | 0 | -273,000 | -70,000 | -33,000 | -123,000 | -956,000 | -302,000 | -33,000 | -111,000 | -614,000 | -875,000 | -364,000 | -68,000 | -754,000 | -229,000 | -33,000 | -1,597,000 | ||||
proceeds from termination of fair value hedge | 0 | ||||||||||||||||||||
net cash from financing activities | -156,008,000 | -12,246,000 | 9,044,000 | -7,411,000 | -19,425,000 | -12,852,000 | -4,198,000 | -33,629,000 | -32,007,000 | -6,509,000 | -17,584,000 | -28,268,000 | -23,900,000 | -20,716,000 | 9,824,000 | ||||||
effect of exchange rate changes on cash | -3,235,000 | 628,000 | -1,819,000 | 16,016,000 | 7,557,000 | -16,595,000 | 11,222,000 | -336,000 | -2,544,000 | 7,000,000 | -5,881,000 | 3,837,000 | 2,413,000 | 8,981,000 | -11,498,000 | ||||||
net decrease in cash and cash equivalents | -15,084,000 | -13,718,000 | -46,909,000 | ||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 54,355,000 | 0 | 0 | 54,307,000 | 0 | 0 | 53,364,000 | 0 | 0 | 65,512,000 | 0 | 0 | 75,871,000 | 0 | |||||
cash and cash equivalents at end of period | -23,706,000 | 20,131,000 | 47,886,000 | -11,775,000 | -653,000 | 56,853,000 | -4,123,000 | 15,392,000 | 38,280,000 | 245,000 | -8,357,000 | 51,794,000 | -19,394,000 | 48,240,000 | 28,962,000 | -7,607,000 | |||||
net increase in cash and cash equivalents | 20,131,000 | -6,469,000 | -653,000 | 2,546,000 | 7,704,000 | -19,394,000 | 22,857,000 | -7,607,000 | |||||||||||||
long-lived asset impairment | 31,000 | 20,666,000 | 694,000 | ||||||||||||||||||
investments and joint ventures, including proceeds from dispositions | |||||||||||||||||||||
cash and cash equivalents at beginning of year | |||||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||||
long-lived asset and intangibles impairment | 1,600,000 | 0 | 244,000 | 0 | |||||||||||||||||
net income | -13,535,000 | -10,376,000 | -18,699,000 | -115,727,000 | 10,966,000 | 6,923,000 | 3,042,000 | 24,531,000 | 30,889,000 | 19,411,000 | 40,485,000 | 34,254,000 | |||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
acquisitions of businesses, net of cash acquired | 489,000 | -5,905,000 | |||||||||||||||||||
borrowings under term loan | 0 | 0 | |||||||||||||||||||
share repurchases | -13,075,000 | -130,472,000 | -89,830,000 | -177,103,000 | -25,769,000 | -8,562,000 | |||||||||||||||
adjustments to reconcile net income from operations to net cash from operating activities: | |||||||||||||||||||||
net income from discontinued operations | 0 | 0 | |||||||||||||||||||
net income from continuing operations | 3,042,000 | 24,531,000 | 30,889,000 | 19,411,000 | 40,485,000 | ||||||||||||||||
gain on sale of assets | 0 | -134,000 | -3,335,000 | -60,000 | 281,000 | 52,000 | -8,645,000 | -276,000 | |||||||||||||
gain on sale of businesses | |||||||||||||||||||||
proceeds from sale of businesses, net and other | |||||||||||||||||||||
adjustments to reconcile net income from continuing operations to net cash from operating activities from continuing operations: | |||||||||||||||||||||
loss on sale of businesses | |||||||||||||||||||||
net cash from operating activities from continuing operations | -18,945,000 | 31,155,000 | 30,445,000 | 37,586,000 | 50,242,000 | 41,987,000 | |||||||||||||||
investment in joint venture | -80,000 | -100,000 | -106,000 | -408,000 | |||||||||||||||||
net cash from investing activities from continuing operations | -4,038,000 | -11,926,000 | -254,291,000 | -18,054,000 | 23,604,000 | -724,000 | |||||||||||||||
proceeds from funding of discontinued operations | |||||||||||||||||||||
net cash from financing activities from continuing operations | 39,929,000 | -35,991,000 | 272,364,000 | -63,515,000 | -51,487,000 | -48,786,000 | |||||||||||||||
effect of exchange rate changes on cash from continuing operations | -9,242,000 | -2,632,000 | -278,000 | -2,926,000 | -84,000 | ||||||||||||||||
cash flows from discontinued operations | |||||||||||||||||||||
cash from operating activities | |||||||||||||||||||||
cash from investing activities | |||||||||||||||||||||
cash from financing activities | |||||||||||||||||||||
effect of exchange rate changes on cash - discontinued operations | |||||||||||||||||||||
net cash from discontinued operations | |||||||||||||||||||||
cash and cash equivalents of continuing operations at end of year | |||||||||||||||||||||
proceeds from sale of businesses and other | |||||||||||||||||||||
equity in net income of equity-method investees | 526,000 | ||||||||||||||||||||
other non-cash items including unrealized currency gains | -1,093,000 | ||||||||||||||||||||
repayments of other debt | -237,000 | -177,000 | -206,000 | ||||||||||||||||||
shares withheld for payment of employee payroll taxes | -1,175,000 | -541,000 | -2,018,000 | ||||||||||||||||||
increase in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions/divestitures: | |||||||||||||||||||||
proceeds from sale of businesses | |||||||||||||||||||||
proceeds from discontinued operations | |||||||||||||||||||||
less: cash and cash equivalents of discontinued operations | |||||||||||||||||||||
proceeds from discontinued operations entities | |||||||||||||||||||||
effect of exchange rate changes on cash from discontinued operations | |||||||||||||||||||||
net cash flows from discontinued operations | |||||||||||||||||||||
net loss from continuing operations | |||||||||||||||||||||
adjustments to reconcile net loss from continuing operations to net cash from operating activities from continuing operations: | |||||||||||||||||||||
stock based compensation | |||||||||||||||||||||
tax (deficiency) benefit from stock based compensation | |||||||||||||||||||||
contingent consideration expense | |||||||||||||||||||||
gain on pre-existing ownership interest in hain pure protein corporation | |||||||||||||||||||||
other non-cash items including unrealized currency losses | |||||||||||||||||||||
increase in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions: | |||||||||||||||||||||
acquisitions of businesses, net of cash acquired and working capital settlements | |||||||||||||||||||||
purchases of property and equipment | |||||||||||||||||||||
proceeds from sale of investment | |||||||||||||||||||||
proceeds from disposals of property and equipment | |||||||||||||||||||||
proceeds from exercises of stock options | |||||||||||||||||||||
borrowings (repayments) of other debt | |||||||||||||||||||||
excess tax benefits from stock based compensation | |||||||||||||||||||||
acquisition related contingent consideration |
